Sign in

Jesus Malave

Director at GE Vernova
Board

About Jesus Malave

Independent director since April 2024; age 56. Currently Chief Financial Officer of Lockheed Martin Corporation; previously held senior finance roles at L3Harris, UTC’s Carrier, and UTC Aerospace Systems. Education: B.A. in Mathematics (University of Connecticut), M.S. in Accounting (University of Hartford), J.D. (University of Connecticut School of Law). Serves on GE Vernova’s Audit and Compensation & Human Capital Committees; the Board assessed him as independent and as an Audit Committee “financial expert.”

Past Roles

OrganizationRoleTenureCommittees/Impact
Lockheed Martin (NYSE: LMT)Chief Financial OfficerJan 2022 – PresentSenior financial leadership; operations and risk responsibilities
L3Harris Technologies (NYSE: LHX)SVP & Chief Financial OfficerJun 2019 – Jan 2022Senior finance leadership
UTC’s Carrier (RTX)VP & Chief Financial OfficerApr 2018 – Jun 2019Senior finance leadership
UTC Aerospace Systems (RTX)Chief Financial OfficerJan 2015 – Apr 2018Senior finance leadership

External Roles

OrganizationRoleTenure
GE VernovaDirectorApr 2024 – Present
Public company boards (other than GEV)None

Board Governance

  • Committees: Audit (member), Compensation & Human Capital (member). Audit met 8 times in 2024; CHCC met 5 times; all members of these committees were independent (100%). The Board determined Malave qualifies as an “audit committee financial expert.”
  • Independence: Board determined Jesus Malave is independent.
  • Attendance: In 2024, each director attended at least 75% of aggregate Board and applicable committee meetings; Board held six meetings and committees held 22 in total.
  • Board engagement: Directors conducted site visits and ongoing education; the Board visited research and manufacturing sites and planned additional visits.

Fixed Compensation

ComponentDetail2024 Value
Cash retainerAnnual non‑employee director retainer (prorated for service starting Apr 2, 2024)$105,000
Equity grant (RSUs)1,329 RSUs granted May 16, 2024; annual award value $185,000 translated at $139.2059 30‑day average from spin‑off; grant-date fair value based on $166.40 closing price$221,146 stock award value; 1,329 RSUs
Other compensationMatching gifts, per director program; Malave had none reported$0
TotalFees + Stock + Other$326,146

Key program terms:

  • RSU vesting: earlier of next annual meeting, first anniversary, change‑in‑control, or termination due to disability/death, subject to service.
  • Deferrals: Directors could defer 100% of equity; in 2024 all non‑employee directors elected to defer awards; payable 30 days after cessation of Board service; accrues dividend equivalents (cash upon delivery).
  • Chair/member fees: Additional cash retainers only for committee chairs; no membership fees; Audit Chair $30,000; CHCC Chair $25,000; Nominating Chair $20,000; Safety & Sustainability Chair $20,000; Board Chair +$180,000.

Performance Compensation

Incentive TypeMetricsPayout/Structure
Director equityNone (time‑based RSUs; no performance metrics for director awards)Time‑based vesting; deferrable at election

Other Directorships & Interlocks

CompanyRelationshipPotential Interlock/Conflict Disclosure
Lockheed MartinCFO (executive role; not a directorship)No related‑party transactions involving Malave disclosed; Board reviews and approves related‑person transactions >$120,000 via Audit Committee policy

No shared directorships for Malave with competitors/suppliers/customers were disclosed.

Expertise & Qualifications

  • Skills: Risk management; finance & accounting; manufacturing & operations; executive experience. Age: 56. Tenure on GEV Board: director since April 2024.
  • Audit Committee “financial expert” designation.
  • Education: B.A. Mathematics (UConn); M.S. Accounting (Univ. of Hartford); J.D. (UConn School of Law).

Equity Ownership

HolderShares Beneficially OwnedShares Underlying RSUs/Options (within 60 days)Total Beneficial% Outstanding
Jesus Malave180 (deferred RSUs not included)18<1% (*)

Additional alignment/controls:

  • No shares pledged as security by named persons.
  • Director stock ownership guideline: $700,000 (5× cash retainer); 5 years to attain; unvested RSUs count; PSUs/options do not.
  • Anti‑hedging/anti‑pledging: Directors prohibited from hedging or pledging Company stock.
  • Section 16 compliance: All officers/directors filed ownership reports timely in 2024.

Governance Assessment

  • Board effectiveness: Dual committee service (Audit; CHCC) plus “financial expert” status supports strong oversight of reporting integrity, compensation design, and human capital strategy. Committee independence and structured charters (risk allocation; cybersecurity; ERM; stock ownership and clawback oversight) bolster investor confidence.
  • Independence & attendance: Board determined Malave is independent; directors met attendance expectations; Board maintained non‑executive independent Chair and regular executive sessions—positive governance signals.
  • Alignment: Malave’s equity grant (deferrable RSUs) and robust director ownership guideline drive skin‑in‑the‑game over his 5‑year compliance window; anti‑hedging/pledging policy reduces misalignment risk.
  • Conflicts/related‑party: No related‑party transactions involving Malave disclosed; Audit Committee reviews related‑person transactions and independence annually.
  • Red flags: None identified—no pledging/hedging, no disclosed related‑party exposure, and timely Section 16 filings. Monitor future ownership growth versus $700,000 guideline for alignment over time.